President - Jean Bellin
Jean Bellin has more than 30 years experience in the biopharmaceutical industry, including sales, marketing, business development, mergers and acquisitions, and general management - both domestic and international. He began his pharmaceutical industry career with 12 years at Eli Lilly & Company, holding positions in sales, marketing and general management in Brazil, the US, the Scandinavian countries and Italy. He then founded and served as Managing Director of DuPont Pharma Italy. In 1993, Mr. Bellin became the head of the international Pharmaceutical division of UCB, then a $2 billion publicly traded, biopharmaceutical and chemical group based in Brussels, Belgium. There he managed the pharmaceutical subsidiaries in the US, Canada, South America, Japan, China and Southeast Asia. Later he managed the Osteohealth and Animal Health global divisions of Luitpold Pharmaceuticals, a wholly-owned company of Sankyo Pharmaceuticals Company Ltd., then the second largest pharmaceutical company in Japan. In 2004 and 2005, he was the CEO of Mountain View Pharmaceuticals Inc., a California-based biopharmaceutical company where the PEGylation of therapeutic proteins was a major focus. In 2006, Jean became the President of Metagenics, a global life sciences company, where Mr. Bellin lead and grew the US and international sales, marketing and manufacturing operations of the company for 4 and a half years. Mr. Bellin left Metagenics in October of 2010 after its acquisition by the Alticor group, the $8.2 billion parent company of Nutrilite, the largest vitamin manufacturer in the world.
Mr. Bellin received his bachelor's degree in Economic, Political and Social Sciences from the Facultés Universitaires Saint Louis in Brussels and a License in Applied Economic Sciences from the Université Catholique de Louvain in Belgium.
Medical Director - Mark Kartub, M.D.
Dr. Kartub received his medical degree from the University of Pittsburgh and completed his pathology residency at Presbyterian-University Hospital. After completing his residency, he was appointed Associate Pathologist at Conemaugh Memorial Hospital, Johnstown, Pennsylvania. He was then called to military duty at the 406th Medical Laboratory, Zama, Japan where he served as Chief of Pathology, Chief of Chemistry, and Deputy Commander. He earned a Commendation Medal for his work there.
Returning to Phoenix, Arizona as Pathologist at St. Luke's Hospital, where he served on many medical staff and administrative committees. He has served on the Boards of Combined Health Resources, St Luke's Medical Center, St Luke's Hospital, Harrington Arthritis Center and was Chairman of the Institutional Research Committee for more than 20 years.
Dr. Kartub's experience and recognized excellence in Pathology lay a foundation of quality and distinction that keeps Cyrex at the head of its field.
Vice President, Education - Jama Lambert
Jama Lambert, a graduate of Bismarck State College and the University of Oregon, is Cyrex's liaison at national and international conferences in the fields of autism and chronic disorders. Her experience with high-complexity immunological laboratory testing allows Ms. Lambert to present the latest advances in testing to healthcare professionals. She has co-published scientific articles with Aristo Vojdani, Ph.D. in peer-reviewed journals and magazines, and worked in numerous video, film, and television productions. Utilizing her unique background, Jama Lambert continues to be a passionate advocate for patients and a creative voice in educating healthcare professionals on the biomedical complexities of environmentally induced disorders.
Chief Scientific Advisor - Aristo Vojdani, Ph.D., M.Sc., C.L.S.
Dr. Aristo Vojdani obtained his Ph.D. in the field of microbiology and clinical immunology with postdoctoral studies in tumor immunology at UCLA. Vojdani's ongoing research, spanning a 40-year career, focuses on the role of environmental factors, such as toxic chemicals, infections and dietary proteins and peptides in complex diseases. An owner of 15 U.S. patents for laboratory assessments, he has published 120 peer-reviewed articles in scientific journals. Dr. Vojdani is CEO and technical director of Immunosciences Lab., Inc. in Los Angeles, CA, a member of the editorial board of four scientific journals, and a guest editor of six journals.